Company page

Clene Inc.

Clene Inc. is a public company traded under the ticker CLNN in the American market, with a market capitalization of approximately $76.8 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Clene is committed to advancing its research and product pipeline to address unmet medical needs in this area.